HR 7035
117th Congress
House
Health
Biologics Market Transparency Act of 2022
Introduced: March 9, 2022
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2022
Referred to the Subcommittee on Health.
Mar 9, 2022
Referred to the House Committee on Energy and Commerce.
Mar 9, 2022
Introduced in House
Plain-English summary
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1